[go: up one dir, main page]

MX2016006464A - Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor. - Google Patents

Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.

Info

Publication number
MX2016006464A
MX2016006464A MX2016006464A MX2016006464A MX2016006464A MX 2016006464 A MX2016006464 A MX 2016006464A MX 2016006464 A MX2016006464 A MX 2016006464A MX 2016006464 A MX2016006464 A MX 2016006464A MX 2016006464 A MX2016006464 A MX 2016006464A
Authority
MX
Mexico
Prior art keywords
etoricoxib
tramadol
hydrochloride
pain
treatment
Prior art date
Application number
MX2016006464A
Other languages
English (en)
Inventor
Daniel Walls Flores Oliver
Astrid Salto Rivera Reyna
Rodríguez Hernández Ramón
Original Assignee
Laboratorios Liomont S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C V filed Critical Laboratorios Liomont S A De C V
Priority to MX2016006464A priority Critical patent/MX2016006464A/es
Priority to EP17798843.3A priority patent/EP3338771A4/en
Priority to PCT/IB2017/052775 priority patent/WO2017199140A1/es
Priority to CA2997600A priority patent/CA2997600A1/en
Priority to US16/008,277 priority patent/US20190060295A1/en
Publication of MX2016006464A publication Critical patent/MX2016006464A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención consiste en un proceso y composición farmacéutica de una combinación de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor, cuyo proceso de obtención está dado a partir de dos activos la cual consiste en gránulos y/o multiparticulados con clorhidrato de tramadol y gránulos y/o multiparticulados con etoricoxib los cuales pueden estar contenidos en una mezcla de polvos, o comprimidos en una tableta bicapa con o sin recubrimiento o en una capsula como granulados y/o tabletas con o sin recubrimiento.
MX2016006464A 2016-05-18 2016-05-18 Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor. MX2016006464A (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
MX2016006464A MX2016006464A (es) 2016-05-18 2016-05-18 Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
EP17798843.3A EP3338771A4 (en) 2016-05-18 2017-05-11 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF TRAMADOL-ETORICOXIB CHLORHYDRATE FOR THE TREATMENT OF PAIN
PCT/IB2017/052775 WO2017199140A1 (es) 2016-05-18 2017-05-11 Composición farmacéutica de una combinación de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor
CA2997600A CA2997600A1 (en) 2016-05-18 2017-05-11 Pharmaceutical composition of a combination of tramadol-etoricoxib hydrochloride for the treatment of pain
US16/008,277 US20190060295A1 (en) 2016-05-18 2017-05-11 Pharmaceutical composition of a combination of tramadol-etoricoxib hydrochloride for the treatment of pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016006464A MX2016006464A (es) 2016-05-18 2016-05-18 Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.

Publications (1)

Publication Number Publication Date
MX2016006464A true MX2016006464A (es) 2017-11-17

Family

ID=60325762

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006464A MX2016006464A (es) 2016-05-18 2016-05-18 Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.

Country Status (5)

Country Link
US (1) US20190060295A1 (es)
EP (1) EP3338771A4 (es)
CA (1) CA2997600A1 (es)
MX (1) MX2016006464A (es)
WO (1) WO2017199140A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4585207A1 (en) 2024-01-12 2025-07-16 Laboratorios Silanes, S.A. de C.V. Synergic and stable pharmaceutical composition of an nsaid and an opioid analgesic for pain and inflammation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017009660A (es) * 2017-07-26 2017-11-23 Laboratorios Liomont S A De C V Composicion farmaceutica con un rango de relacion entre el clorhidrato de tramadol y el etoricoxib para su administracion para el tratamiento del dolor.
MX2018013070A (es) 2017-12-29 2019-10-15 Gruenenthal Gmbh Combinación farmacéutica que comprende clorhidrato de tramadol de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051685A1 (en) * 1999-03-01 2000-09-08 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and a selective cox-2 inhibitor drug
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
EP2177215A1 (en) * 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
EP2281558A1 (en) * 2009-08-06 2011-02-09 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors
EP2311446A1 (en) * 2009-10-16 2011-04-20 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising Tramadol and Celecoxib in the treatment of pain
SG178835A1 (en) * 2009-10-16 2012-05-30 Esteve Labor Dr Co-crystals of tramadol and coxibs
HUE033525T2 (en) * 2012-08-27 2017-12-28 Cadila Healthcare Ltd Pharmaceuticals containing Etoricoxib

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4585207A1 (en) 2024-01-12 2025-07-16 Laboratorios Silanes, S.A. de C.V. Synergic and stable pharmaceutical composition of an nsaid and an opioid analgesic for pain and inflammation

Also Published As

Publication number Publication date
US20190060295A1 (en) 2019-02-28
EP3338771A4 (en) 2019-05-08
EP3338771A1 (en) 2018-06-27
CA2997600A1 (en) 2017-11-23
WO2017199140A1 (es) 2017-11-23

Similar Documents

Publication Publication Date Title
PH12018502268A1 (en) Amide-substituted pyridinyltriazole derivatives and uses thereof
PH12016501724A1 (en) Isoindolinone compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
MX2018015656A (es) Compuestos heterociclicos como antibacterianos.
SG10201900648SA (en) Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide
MX2016013029A (es) Compuestos de indanona sustituidos como modulares de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados.
MX2018000546A (es) Composiciones farmaceuticas que contienen celecoxib y tramadol.
MX2017016055A (es) Moduladores alostericos positivos del receptor muscarinico m2.
PH12016501619A1 (en) Substituted fused heterocycles as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
MX2017006437A (es) Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor.
MX2016006604A (es) Derivados de piperidina con actividad multimodal contra el dolor.
HK1257296A1 (zh) 新的化合物及其用途
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
MX2016006464A (es) Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
PH12018500814A1 (en) Oxadiazaspiro compounds for the treatment of drug abuse and addiction
MX2017006513A (es) Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor.
SG11201901973RA (en) 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
MX2018001239A (es) Amida seleccionada de acido gamma-hidroxibutirico y usos de la misma en el tratamiento de abuso de alcohol.
MX2018014185A (es) Combinacion de antagonistas puros del receptor 5 ht6 con inhibidores de la acetilcolinesterasa.
EA033297B1 (ru) Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы
MX2018014136A (es) Derivados de tetrahidropirano y tiopirano que tienen actividad multimodal contra el dolor.
MX2014005153A (es) Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
PH12018500682A1 (en) Oxa-diazaspiro compounds having activity against pain
MX2017009660A (es) Composicion farmaceutica con un rango de relacion entre el clorhidrato de tramadol y el etoricoxib para su administracion para el tratamiento del dolor.
MX2018004774A (es) Derivados de morfolina sustituidos que tienen actividad contra el dolor.
MX2018000418A (es) Derivados de amida que tienen actividad multimodal contra el dolor.